01 2APOTEX INC
02 2BAUSCH HEALTH, CANADA INC.
03 2JAMP PHARMA CORPORATION
04 2MINT PHARMACEUTICALS INC
05 2PHARMASCIENCE INC
06 2PRO DOC LIMITEE
01 12ZOLPIDEM TARTRATE
01 12TABLET (ORALLY DISINTEGRATING)
01 2APO-ZOLPIDEM ODT
02 2JAMP ZOLPIDEM ODT
03 2MINT-ZOLPIDEM ODT
04 2PMS-ZOLPIDEM ODT
05 2PRO-ZOLPIDEM ODT
06 2SUBLINOX
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : APO-ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging : 30/100/500
Approval Date :
Application Number : 2436159
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : APO-ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 30/100/500
Approval Date :
Application Number : 2434946
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : SUBLINOX
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 10/30/100
Approval Date :
Application Number : 2370433
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : SUBLINOX
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging : 10/30/100
Approval Date :
Application Number : 2391678
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : JAMP ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 2540592
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : JAMP ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 2540606
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : MINT-ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 2472821
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : MINT-ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 2472848
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : PMS-ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 30
Approval Date :
Application Number : 2436183
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
Brand Name : PMS-ZOLPIDEM ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging : 30
Approval Date :
Application Number : 2436175
Regulatory Info : Targeted (CDSA IV)
Registration Country : Canada
LOOKING FOR A SUPPLIER?